Literature DB >> 11262721

Normative data on the Boston Naming Test and two equivalent 30-item short forms.

J Saxton1, G Ratcliff, C A Munro, E C Coffey, J T Becker, L Fried, L Kuller.   

Abstract

Because of the significance of the Boston Naming Test (BNT) in the differential diagnosis of the dementias, especially Alzheimer's disease, adequate norms from community-dwelling elderly individuals are essential. The present study describes the development of two new empirically derived equivalent short forms (30 items each) of the test. Normative data for the total BNT and the two equivalent 30-item halves based on item difficulty are presented using the performance of 314 community-dwelling individuals aged 65 and over. Age and education norms are presented using an overlapping midpoint interval strategy.

Entities:  

Mesh:

Year:  2000        PMID: 11262721     DOI: 10.1076/clin.14.4.526.7204

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  40 in total

1.  Auditory confrontation naming in Alzheimer's disease.

Authors:  Jason Brandt; Arnold Bakker; David Aaron Maroof
Journal:  Clin Neuropsychol       Date:  2010-10-27       Impact factor: 3.535

2.  Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia.

Authors:  J Saxton; B E Snitz; O L Lopez; D G Ives; L O Dunn; A Fitzpatrick; M C Carlson; S T Dekosky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-03-11       Impact factor: 10.154

3.  Diagnostic accuracy and practice effects in the National Alzheimer's Coordinating Center Uniform Data Set neuropsychological battery.

Authors:  Melissa Mathews; Erin Abner; Richard Kryscio; Gregory Jicha; Gregory Cooper; Charles Smith; Allison Caban-Holt; Frederick A Schmitt
Journal:  Alzheimers Dement       Date:  2014-03-20       Impact factor: 21.566

4.  Hearing impairment and cognitive decline: a pilot study conducted within the atherosclerosis risk in communities neurocognitive study.

Authors:  Jennifer A Deal; A Richey Sharrett; Marilyn S Albert; Josef Coresh; Thomas H Mosley; David Knopman; Lisa M Wruck; Frank R Lin
Journal:  Am J Epidemiol       Date:  2015-04-04       Impact factor: 4.897

5.  The use of the picture-word interference paradigm to examine naming abilities in aphasic individuals.

Authors:  Naomi Hashimoto; Cynthia K Thompson
Journal:  Aphasiology       Date:  2010       Impact factor: 2.773

6.  Morphometric and histologic substrates of cingulate integrity in elders with exceptional memory capacity.

Authors:  Tamar Gefen; Melanie Peterson; Steven T Papastefan; Adam Martersteck; Kristen Whitney; Alfred Rademaker; Eileen H Bigio; Sandra Weintraub; Emily Rogalski; M-Marsel Mesulam; Changiz Geula
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

7.  You don't say: dynamic aphasia, another variant of primary progressive aphasia?

Authors:  David L Perez; Bradford C Dickerson; Scott M McGinnis; Daisy Sapolsky; Keith Johnson; Meghan Searl; Kirk R Daffner
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Von Economo neurons of the anterior cingulate across the lifespan and in Alzheimer's disease.

Authors:  Tamar Gefen; Steven T Papastefan; Aras Rezvanian; Eileen H Bigio; Sandra Weintraub; Emily Rogalski; M-Marsel Mesulam; Changiz Geula
Journal:  Cortex       Date:  2017-11-08       Impact factor: 4.027

9.  Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.

Authors:  Yujing Zhao; Dana L Tudorascu; Oscar L Lopez; Ann D Cohen; Chester A Mathis; Howard J Aizenstein; Julie C Price; Lewis H Kuller; M Ilyas Kamboh; Steven T DeKosky; William E Klunk; Beth E Snitz
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

10.  Superior memory and higher cortical volumes in unusually successful cognitive aging.

Authors:  Theresa M Harrison; Sandra Weintraub; M-Marsel Mesulam; Emily Rogalski
Journal:  J Int Neuropsychol Soc       Date:  2012-11       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.